Wall Street Zen upgraded shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) from a sell rating to a hold rating in a research note published on Sunday morning. Several other research analysts have also issued reports on the company. Leerink Partners initiated coverage on Avalo Therapeutics in a research report on Monday, July 6th. They […]

Connect Biopharma (NASDAQ:CNTB – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday. CNTB has been the topic of a number of other reports. Canaccord Genuity Group set a $7.00 price target on shares of Connect Biopharma in a […]

Jianzhi Education Technology Group (NASDAQ:JZ – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Jianzhi Education Technology Group in a report on Tuesday, June […]

Wall Street Zen upgraded shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) from a sell rating to a hold rating in a report released on Sunday. Other equities research analysts have also issued research reports about the company. Freedom Capital raised Atara Biotherapeutics from a “strong sell” rating to a “hold” rating in a research […]

Ovid Therapeutics (NASDAQ:OVID – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday. Other equities analysts have also issued research reports about the company. Oppenheimer increased their target price on Ovid Therapeutics from $7.00 to $9.00 and […]

Wall Street Zen upgraded shares of bioAffinity Technologies (NASDAQ:BIAF – Free Report) from a sell rating to a hold rating in a research report report published on Monday morning. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of bioAffinity Technologies in a research note on Monday, July 20th. One research analyst has rated […]

Upstart (NASDAQ:UPST – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday. UPST has been the subject of a number of other reports. Citigroup dropped their target price on shares of Upstart from $80.00 to $61.00 and set […]

Oxford Square Capital (NASDAQ:OXSQ – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday. Separately, Weiss Ratings lowered shares of Oxford Square Capital from a “sell (d+)” rating to a “sell (d)” rating in a […]

Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Several other research firms also recently commented on ORKA. Wedbush set a $165.00 target price on shares of Oruka Therapeutics in […]